Skip to main content
Clinical Trials/NCT00292123
NCT00292123
Completed
Phase 1

Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse

National Institute on Drug Abuse (NIDA)0 sites200 target enrollmentJune 1999

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Opioid Dependence
Sponsor
National Institute on Drug Abuse (NIDA)
Enrollment
200
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The primary goal of this study is to determine how contingency management can best be combined with standard or high doses of methadone to increase simultaneous abstinence from heroin and cocaine.

Detailed Description

A study of people pmaintained on Methadone using contingency management

Registry
clinicaltrials.gov
Start Date
June 1999
End Date
August 2006
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Opioid dependence; cocaine use

Exclusion Criteria

  • Medical or psychiatric conditions that would contraindicate participation in a methadone maintenance study; inability to give informed consent; inability to attend clinic seven days a week

Outcomes

Primary Outcomes

Not specified

Similar Trials